Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk?

@article{Fish2011Part1H,
  title={Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk?},
  author={Jonathan D Fish},
  journal={Journal of pediatric and adolescent gynecology},
  year={2011},
  volume={24 2},
  pages={98-101}
}
  • Jonathan D Fish
  • Published 2011 in Journal of pediatric and adolescent gynecology
Survivors of childhood cancer represent a rapidly growing population of patients, some of whom experience temporary or permanent premature ovarian failure (POF) as a consequence of their disease or treatment. Although the risks and benefits of exogenous hormones have been extensively explored in menopausal women 50 years of age and older, there is scant data on the long-term safety of exogenous hormones in childhood cancer survivors. Although there are certainly benefits that can be achieved… CONTINUE READING